- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/82 - Translation products from oncogenes
Patent holdings for IPC class C07K 14/82
Total number of patents in this class: 659
10-year publication summary
47
|
47
|
51
|
57
|
54
|
55
|
54
|
55
|
33
|
11
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
39 |
Immatics Biotechnologies GmbH | 1144 |
24 |
International Institute of Cancer Immunology, Inc. | 74 |
18 |
Htyr Acquisition LLC | 21 |
15 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
10 |
Dana-Farber Cancer Institute, Inc. | 2455 |
8 |
The Trustees of the University of Pennsylvania | 4122 |
7 |
Foundation Medicine, Inc. | 260 |
7 |
Vib VZW | 799 |
7 |
Centre National de La Recherche Scientifique | 9632 |
6 |
The Johns Hopkins University | 5377 |
6 |
The Board of Trustees of the University of Illinois | 2623 |
6 |
Chimera Bioengineering, Inc. | 42 |
6 |
Fundacio Privada Institut D'investigacio Oncologica de Vall Hebron | 53 |
6 |
Japanese Foundation for Cancer Research | 155 |
6 |
Katholieke Universiteit Leuven | 1035 |
6 |
Medicenna Therapeutics Inc. | 35 |
6 |
Riken | 1669 |
6 |
Taisho Pharmaceutical Co., Ltd. | 844 |
6 |
Board of Regents, The University of Texas System | 5370 |
5 |
Other owners | 459 |